Communiqués de presse MHRA — Medicines and Healthcare products Regulatory Agency — Flux RSS et veille en direct
PPN World suit le flux RSS de MHRA — Medicines and Healthcare products Regulatory Agency en temps réel — 15 communiqués indexés au cours des 30 derniers jours, le plus récent est arrivé il y a 6 j. Suivez-le avec alertes sur recherches enregistrées, résumés IA et recherche plein texte, ou branchez l'URL RSS ci-dessous dans votre propre lecteur.
URL du flux RSS de MHRA — Medicines and Healthcare products Regulatory Agency
https://www.gov.uk/search/news-and-communications.atom?organisations%5B%5D=medicines-and-healthcare-products-regulatory-agencyÀ propos de ce fil
MHRA — Medicines and Healthcare products Regulatory Agency fait partie des 1200+ fils de presse que PPN World surveille en continu — un fil en anglais axé sur le secteur Santé & sciences de la vie, classé sous « Royaume-Uni » dans notre index par pays. Chaque communiqué est dédupliqué, géolocalisé et enrichi d'un résumé IA, et vous pouvez y attacher des alertes sur recherches enregistrées. Au cours des 30 derniers jours, MHRA — Medicines and Healthcare products Regulatory Agency a publié 15 communiqués, surtout le mercredi.
Comment suivre les communiqués de MHRA — Medicines and Healthcare products Regulatory Agency
- Copiez l'URL du flux RSS de MHRA — Medicines and Healthcare products Regulatory Agency affichée ci-dessus.
- Collez-la dans n'importe quel lecteur RSS (Feedly, Inoreader, NetNewsWire…) pour recevoir le flux brut.
- Ou suivez MHRA — Medicines and Healthcare products Regulatory Agency dans PPN World pour ajouter déduplication, alertes sur recherches enregistrées et résumés IA sur les 1200+ fils.
Derniers communiqués de MHRA — Medicines and Healthcare products Regulatory Agency
- Thousands of patients to benefit from new daily pill for serious heart condition following co-ordinated MHRA and NICE decisionsil y a 3 h
Aficamten is recommended by NICE at the same time it was approved by the MHRA, thanks to improvements driven by closer working between the two organisations.
- Pioneering AI health innovations regulatory sandbox launchedil y a 4 h
The London sandbox is a secure environment designed to safely test AI-enabled devices in a real-world environment so patients can benefit more quickly.
- Beat the heat: MHRA urges people to take extra care with medical devices this summeril y a 1 j
Simple steps to help keep your essential medical equipment working safely when temperatures rise.
- MHRA clarifies regulatory status of ambient voice technologies used in the NHSil y a 1 j
The Medicines and Healthcare products Regulatory Agency has published guidance, developed in close partnership with NHS England, clarifying how existing medical device law applies to ambient voice tec…
- No summer shortcut for safe weight lossil y a 6 j
As demand for weight-loss medicines continues to rise, the MHRA is reminding people how to use GLP-1 medicines safely, spot illegal sellers, and avoid diet changes that could interfere with their medi…
- MHRA approves world's first lower-carbon beclometasone inhalers for patients with asthmail y a 9 j
The new inhalers use a next-generation propellant designed to reduce environmental impact while maintaining the same established treatment.
- Hot cars, hot luggage: why where you store your medicines matters this summeril y a 13 j
As part of the ‘Summer-proof your health’ campaign, the MHRA is reminding people that heat and poor storage, at home or while travelling, can affect how well some medicines work.
- MHRA delivers record performance as 2025-26 Annual Report and Accounts confirms growing global influenceil y a 14 j
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2025–26 Annual Report and Accounts highlighting a year of strong and consistent delivery as set out in the agency’s fir…
- Updated warnings for botulinum toxin products following rare cases of botulismil y a 14 j
The MHRA is strengthening safety warnings for all botulinum toxin type A products, following reports of rare cases of botulism linked to their use.
- UK-donor plasma given go-ahead for new medicinesil y a 14 j
Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of UK‑donor plasma for five high‑priority plasma-derived medicinal products.
- Yellow Cards: bad in football; brilliant in patient safetyil y a 20 j
As football fans across the country get behind England, the MHRA wants to keep any Yellow Cards off the pitch – and instead let people know that Yellow Cards can make an important impact in a very dif…
- Heat, travel and late nights: How summer can affect your medicines and how to stay safeil y a 21 j
The MHRA is urging people to “summer-proof your health” as warmer weather, travel, and changing routines can affect how medicines and medical devices work, with simple steps to help prevent avoidable…
Les plus récents communiqués de ce fil défilent en direct pour les membres PPN World.